SHL Stock Overview
Offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Sonic Healthcare Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$26.27 |
52 Week High | AU$32.57 |
52 Week Low | AU$23.58 |
Beta | 0.51 |
11 Month Change | -6.58% |
3 Month Change | -0.38% |
1 Year Change | -13.36% |
33 Year Change | -33.22% |
5 Year Change | -7.17% |
Change since IPO | 26,170.00% |
Recent News & Updates
Recent updates
Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 93% Above Its Share Price
Jul 27These 4 Measures Indicate That Sonic Healthcare (ASX:SHL) Is Using Debt Reasonably Well
Jun 24Sonic Healthcare Limited (ASX:SHL) Investors Are Less Pessimistic Than Expected
May 08Sonic Healthcare's (ASX:SHL) Returns On Capital Not Reflecting Well On The Business
Apr 24Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 90% Above Its Share Price
Mar 07Returns On Capital At Sonic Healthcare (ASX:SHL) Have Hit The Brakes
Dec 26Is Sonic Healthcare Limited (ASX:SHL) Trading At A 46% Discount?
Dec 08Here's Why Sonic Healthcare (ASX:SHL) Can Manage Its Debt Responsibly
Nov 23It's Unlikely That The CEO Of Sonic Healthcare Limited (ASX:SHL) Will See A Huge Pay Rise This Year
Nov 09Returns At Sonic Healthcare (ASX:SHL) Appear To Be Weighed Down
Sep 19Sonic Healthcare (ASX:SHL) Will Pay A Larger Dividend Than Last Year At A$0.62
Sep 02Sonic Healthcare (ASX:SHL) Has Announced That It Will Be Increasing Its Dividend To A$0.62
Aug 19Is Sonic Healthcare Limited (ASX:SHL) Trading At A 31% Discount?
Aug 10Returns Are Gaining Momentum At Sonic Healthcare (ASX:SHL)
May 24Is Sonic Healthcare Limited (ASX:SHL) Trading At A 28% Discount?
May 11We Think Sonic Healthcare (ASX:SHL) Can Stay On Top Of Its Debt
Apr 28Sonic Healthcare's (ASX:SHL) Upcoming Dividend Will Be Larger Than Last Year's
Mar 03We Like Sonic Healthcare's (ASX:SHL) Returns And Here's How They're Trending
Feb 17Are Investors Undervaluing Sonic Healthcare Limited (ASX:SHL) By 22%?
Feb 04Here's Why We Think Sonic Healthcare (ASX:SHL) Is Well Worth Watching
Dec 04Here's Why Shareholders May Consider Paying Sonic Healthcare Limited's (ASX:SHL) CEO A Little More
Nov 10Investors Should Be Encouraged By Sonic Healthcare's (ASX:SHL) Returns On Capital
Nov 08Is There An Opportunity With Sonic Healthcare Limited's (ASX:SHL) 36% Undervaluation?
Oct 26Is Sonic Healthcare (ASX:SHL) Using Too Much Debt?
Sep 21Sonic Healthcare (ASX:SHL) Will Pay A Larger Dividend Than Last Year At A$0.60
Aug 26Does Sonic Healthcare (ASX:SHL) Deserve A Spot On Your Watchlist?
Aug 24We Like Sonic Healthcare's (ASX:SHL) Returns And Here's How They're Trending
Aug 07Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 62% Above Its Share Price
Jun 26Does Sonic Healthcare (ASX:SHL) Deserve A Spot On Your Watchlist?
May 10Shareholders Would Enjoy A Repeat Of Sonic Healthcare's (ASX:SHL) Recent Growth In Returns
Apr 28A Look At The Fair Value Of Sonic Healthcare Limited (ASX:SHL)
Mar 19Sonic Healthcare's (ASX:SHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 23Investors Should Be Encouraged By Sonic Healthcare's (ASX:SHL) Returns On Capital
Jan 22Is Sonic Healthcare (ASX:SHL) Using Too Much Debt?
Dec 26A Look At The Intrinsic Value Of Sonic Healthcare Limited (ASX:SHL)
Dec 14We Like Sonic Healthcare's (ASX:SHL) Returns And Here's How They're Trending
Oct 23With EPS Growth And More, Sonic Healthcare (ASX:SHL) Is Interesting
Oct 12Does Sonic Healthcare (ASX:SHL) Have A Healthy Balance Sheet?
Sep 15Is Sonic Healthcare Limited (ASX:SHL) Worth AU$42.5 Based On Its Intrinsic Value?
Aug 26Does Sonic Healthcare (ASX:SHL) Deserve A Spot On Your Watchlist?
Jul 12Sonic Healthcare (ASX:SHL) Seems To Use Debt Rather Sparingly
Jun 11Returns On Capital Are Showing Encouraging Signs At Sonic Healthcare (ASX:SHL)
May 26Shareholder Returns
SHL | AU Healthcare | AU Market | |
---|---|---|---|
7D | -3.5% | -0.1% | -0.008% |
1Y | -13.4% | -8.1% | 15.0% |
Return vs Industry: SHL underperformed the Australian Healthcare industry which returned -8.1% over the past year.
Return vs Market: SHL underperformed the Australian Market which returned 15% over the past year.
Price Volatility
SHL volatility | |
---|---|
SHL Average Weekly Movement | 2.5% |
Healthcare Industry Average Movement | 5.0% |
Market Average Movement | 8.7% |
10% most volatile stocks in AU Market | 16.7% |
10% least volatile stocks in AU Market | 3.6% |
Stable Share Price: SHL has not had significant price volatility in the past 3 months.
Volatility Over Time: SHL's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1934 | 41,000 | Colin Goldschmidt | www.sonichealthcare.com |
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services.
Sonic Healthcare Limited Fundamentals Summary
SHL fundamental statistics | |
---|---|
Market cap | AU$12.70b |
Earnings (TTM) | AU$511.09m |
Revenue (TTM) | AU$8.97b |
24.7x
P/E Ratio1.4x
P/S RatioIs SHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SHL income statement (TTM) | |
---|---|
Revenue | AU$8.97b |
Cost of Revenue | AU$6.02b |
Gross Profit | AU$2.94b |
Other Expenses | AU$2.43b |
Earnings | AU$511.09m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.06 |
Gross Margin | 32.84% |
Net Profit Margin | 5.70% |
Debt/Equity Ratio | 37.0% |
How did SHL perform over the long term?
See historical performance and comparison